{
    "info": {
        "nct_id": "NCT05640193",
        "official_title": "Pilot Trial of Lifileucel (LN-144) for Patients With Asymptomatic Melanoma Brain Metastases and Progression on Prior PD1 Therapy",
        "inclusion_criteria": "1. Metastatic melanoma with asymptomatic brain metastases\n2. At least one resectable lesion (or aggregate of lesions resected) of a minimum 1.5 cm in diameter post-resection to generate TIL\n3. Must be ≥ 18 years of age at time of consent\n4. ECOG performance status of 0-1 and estimated life expectancy of ≥ 3 months\n5. Adequate hematologic parameters and organ function\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "1. Received organ allograft, except kidney transplant, or prior cell transfer therapy including TIL and CAR-T therapies\n2. Ongoing grade 2-4 toxicity from prior immunotherapy (excluding endocrine, ocular toxicity or vitiligo)\n3. History of hypersensitivity to any component or excipient of lifileucel or other treatment regimen drugs\n4. Symptomatic brain metastases\n5. Chronic systemic steroid therapy of > 10 mg/day\n6. Active medical illness(es) that would pose increased risk for protocol participation\n7. Must have negative syphilis assay and be seronegative for HIV, positive serology for HBV must have corresponding PCR assay and may be enrolled if viral load by PCR is undetectable\n8. Primary immunodeficiency\n9. Received live or attenuated vaccine within 28 days prior to beginning NMA-LD\n10. Pregnant or breastfeeding\n11. Patients who cannot receive gadolinium-enhanced MRI.",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "1. Metastatic melanoma with asymptomatic brain metastases",
            "criterions": [
                {
                    "exact_snippets": "Metastatic melanoma",
                    "criterion": "melanoma",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": "metastatic"
                        }
                    ]
                },
                {
                    "exact_snippets": "asymptomatic brain metastases",
                    "criterion": "brain metastases",
                    "requirements": [
                        {
                            "requirement_type": "symptom status",
                            "expected_value": "asymptomatic"
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. ECOG performance status of 0-1 and estimated life expectancy of ≥ 3 months",
            "criterions": [
                {
                    "exact_snippets": "ECOG performance status of 0-1",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 1,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "estimated life expectancy of ≥ 3 months",
                    "criterion": "life expectancy",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "months"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Must be ≥ 18 years of age at time of consent",
            "criterions": [
                {
                    "exact_snippets": "Must be ≥ 18 years of age at time of consent",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "age at time of consent",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. At least one resectable lesion (or aggregate of lesions resected) of a minimum 1.5 cm in diameter post-resection to generate TIL",
            "criterions": [
                {
                    "exact_snippets": "At least one resectable lesion (or aggregate of lesions resected)",
                    "criterion": "resectable lesion",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "N/A"
                            }
                        },
                        {
                            "requirement_type": "resectability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "minimum 1.5 cm in diameter post-resection",
                    "criterion": "lesion diameter post-resection",
                    "requirements": [
                        {
                            "requirement_type": "size",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1.5,
                                "unit": "cm"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "8. Primary immunodeficiency",
            "criterions": [
                {
                    "exact_snippets": "Primary immunodeficiency",
                    "criterion": "primary immunodeficiency",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. History of hypersensitivity to any component or excipient of lifileucel or other treatment regimen drugs",
            "criterions": [
                {
                    "exact_snippets": "History of hypersensitivity to any component or excipient of lifileucel",
                    "criterion": "hypersensitivity to lifileucel components or excipients",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "History of hypersensitivity to ... other treatment regimen drugs",
                    "criterion": "hypersensitivity to other treatment regimen drugs",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "11. Patients who cannot receive gadolinium-enhanced MRI.",
            "criterions": [
                {
                    "exact_snippets": "Patients who cannot receive gadolinium-enhanced MRI",
                    "criterion": "ability to receive gadolinium-enhanced MRI",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "7. Must have negative syphilis assay and be seronegative for HIV, positive serology for HBV must have corresponding PCR assay and may be enrolled if viral load by PCR is undetectable",
            "criterions": [
                {
                    "exact_snippets": "Must have negative syphilis assay",
                    "criterion": "syphilis assay",
                    "requirements": [
                        {
                            "requirement_type": "result",
                            "expected_value": "negative"
                        }
                    ]
                },
                {
                    "exact_snippets": "seronegative for HIV",
                    "criterion": "HIV serology",
                    "requirements": [
                        {
                            "requirement_type": "serostatus",
                            "expected_value": "negative"
                        }
                    ]
                },
                {
                    "exact_snippets": "positive serology for HBV must have corresponding PCR assay",
                    "criterion": "HBV serology and PCR assay",
                    "requirements": [
                        {
                            "requirement_type": "serostatus",
                            "expected_value": "positive"
                        },
                        {
                            "requirement_type": "PCR assay",
                            "expected_value": "performed"
                        }
                    ]
                },
                {
                    "exact_snippets": "may be enrolled if viral load by PCR is undetectable",
                    "criterion": "HBV viral load by PCR",
                    "requirements": [
                        {
                            "requirement_type": "viral load",
                            "expected_value": "undetectable"
                        }
                    ]
                }
            ]
        },
        {
            "line": "6. Active medical illness(es) that would pose increased risk for protocol participation",
            "criterions": [
                {
                    "exact_snippets": "Active medical illness(es) that would pose increased risk for protocol participation",
                    "criterion": "active medical illness",
                    "requirements": [
                        {
                            "requirement_type": "risk for protocol participation",
                            "expected_value": "increased"
                        }
                    ]
                }
            ]
        },
        {
            "line": "9. Received live or attenuated vaccine within 28 days prior to beginning NMA-LD",
            "criterions": [
                {
                    "exact_snippets": "Received live or attenuated vaccine within 28 days prior to beginning NMA-LD",
                    "criterion": "live or attenuated vaccine administration",
                    "requirements": [
                        {
                            "requirement_type": "time since administration",
                            "expected_value": {
                                "operator": "<=",
                                "value": 28,
                                "unit": "days prior to beginning NMA-LD"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. Chronic systemic steroid therapy of > 10 mg/day",
            "criterions": [
                {
                    "exact_snippets": "Chronic systemic steroid therapy",
                    "criterion": "systemic steroid therapy",
                    "requirements": [
                        {
                            "requirement_type": "chronicity",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "> 10 mg/day",
                    "criterion": "systemic steroid therapy dosage",
                    "requirements": [
                        {
                            "requirement_type": "dosage",
                            "expected_value": {
                                "operator": ">",
                                "value": 10,
                                "unit": "mg/day"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Received organ allograft, except kidney transplant, or prior cell transfer therapy including TIL and CAR-T therapies",
            "criterions": [
                {
                    "exact_snippets": "Received organ allograft, except kidney transplant",
                    "criterion": "organ allograft",
                    "requirements": [
                        {
                            "requirement_type": "history of receipt",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "organ type",
                            "expected_value": {
                                "operator": "!=",
                                "value": 1,
                                "unit": "kidney transplant"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "prior cell transfer therapy including TIL and CAR-T therapies",
                    "criterion": "cell transfer therapy",
                    "requirements": [
                        {
                            "requirement_type": "history of prior therapy",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "therapy type",
                            "expected_value": [
                                "TIL",
                                "CAR-T"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "10. Pregnant or breastfeeding",
            "criterions": [
                {
                    "exact_snippets": "Pregnant",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "breastfeeding",
                    "criterion": "breastfeeding status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Ongoing grade 2-4 toxicity from prior immunotherapy (excluding endocrine, ocular toxicity or vitiligo)",
            "criterions": [
                {
                    "exact_snippets": "Ongoing grade 2-4 toxicity from prior immunotherapy",
                    "criterion": "toxicity from prior immunotherapy",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "ongoing"
                        },
                        {
                            "requirement_type": "grade",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 2,
                                        "unit": ""
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 4,
                                        "unit": ""
                                    }
                                ]
                            }
                        },
                        {
                            "requirement_type": "type",
                            "expected_value": "toxicity"
                        }
                    ]
                },
                {
                    "exact_snippets": "excluding endocrine, ocular toxicity or vitiligo",
                    "criterion": "toxicity type",
                    "requirements": [
                        {
                            "requirement_type": "exclusion",
                            "expected_value": [
                                "endocrine toxicity",
                                "ocular toxicity",
                                "vitiligo"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. Symptomatic brain metastases",
            "criterions": [
                {
                    "exact_snippets": "Symptomatic brain metastases",
                    "criterion": "brain metastases",
                    "requirements": [
                        {
                            "requirement_type": "symptomatic",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [
        {
            "line": "5. Adequate hematologic parameters and organ function",
            "criterions": [
                {
                    "exact_snippets": "Adequate hematologic parameters",
                    "criterion": "hematologic parameters",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "adequate ... organ function",
                    "criterion": "organ function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}